Case Study

A Multiple Sclerosis Clinical Trial Collaboration

A Multiple Sclerosis Clinical Trial Collaboration

GeNeuro and Worldwide Clinical Trials collaborated on the development of a new, exciting molecule for the treatment of multiple sclerosis (MS). GeNeuro was founded in 2006 to work on endogenous retroviruses, with the mission of developing new drugs and treating patients with neurodegenerative and autoimmune disorders by neutralizing these causal factors. The company’s lead product is a monoclonal antibody targeting the protein pHERV-W Env of endogenous retroviral origin.

VIEW THE CASE STUDY!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Clinical Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: